Table III.
Clinicopathological characteristics | Hazard ratio (95% Cl) | P-value |
---|---|---|
Univariate analysis | ||
Age >55 years | 0.929 (0.652-1.323) | 0.682 |
Male sex | 0.941 (0.665-1.331) | 0.730 |
Adenocarcinoma | 1.238(0.875-1.752) | 0.227 |
Poor differentiation | 1.155(0.786-1.697) | 0.464 |
High TNM stage | 0.993(0.701-1.406) | 0.968 |
Positive lymph node metastasis | 1.797 (1.271-2.540) | 0.001 |
Positive ANKHD1 expression | 1.698(1.149-2.509) | 0.008 |
Multivariate analysis | ||
Positive lymph node metastasis | 2.299 (1.449-3.648) | 0.000 |
Positive ANKHD1 expression | 1.564(1.032-2.370) | 0.035 |
ANKHD1, ankyrin repeat and KH domain-containing 1; NSCLC, non-small-cell lung cancer; YAP, yes-associated protein.